ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,963Medicare Part D Prescriptions Filled, Including Refills

Rank: 69 out of 917

$588K Total Retail Price of All Prescriptions

Rank: 77 out of 917

506 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 506 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 506 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 10,457 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 487 481 1 2
LEVOTHYROXINE SODIUM 473 454 2 3
OMEPRAZOLE 371 336 3 4
LISINOPRIL 312 290 4 1
HYDROCODONE-ACETAMINOPHEN 280 278 S3 5 6
POTASSIUM CHLORIDE 253 253 6 16
FUROSEMIDE 239 238 7 7
AMLODIPINE BESYLATE 234 231 8 5
METFORMIN HCL 216 209 9 8
HYDROCHLOROTHIAZIDE 214 211 10 9
ATORVASTATIN CALCIUM 203 196 11 14
WARFARIN SODIUM 185 185 12 10
LOSARTAN POTASSIUM 181 178 13 13
TAMSULOSIN HCL 169 164 14 25
ZOLPIDEM TARTRATE 168 168 15 21
METOPROLOL SUCCINATE 164 162 16 18
CITALOPRAM HBR 147 131 17 15
DONEPEZIL HCL 135 135 18 32
METOPROLOL TARTRATE 131 128 19 11
PRAVASTATIN SODIUM 117 106 20 20
ENALAPRIL MALEATE 115 112 21 79
GABAPENTIN 114 105 22 17
SERTRALINE HCL 111 109 23 24
ATENOLOL 107 105 24 12
ALLOPURINOL 104 104 25 31
PANTOPRAZOLE SODIUM 98 96 26 44
ZETIA 96 90 27 93
TRAZODONE HCL 92 75 28 22
LANTUS 89 83 29 37
DILTIAZEM 24HR CD 88 88 30 95
ALENDRONATE SODIUM 87 83 31 23
ISOSORBIDE MONONITRATE ER 79 79 32 70
AMITRIPTYLINE HCL 73 70 R 33 67
PREMARIN 70 70 R 34 146
EVISTA 70 70 34 130
TRIAMTERENE-HCTZ 69 69 36 36
KLOR-CON 10 68 68 37 115
TRAMADOL HCL 68 66 37 28
VERAPAMIL ER 67 67 39 145
CELEBREX 65 65 40 124
CLOPIDOGREL 63 62 41 50
GLIPIZIDE ER 63 63 41 128
RANITIDINE HCL 63 62 41 29
DIGOXIN 62 62 44 41
PREDNISONE 62 57 44 34
FENTANYL 61 50 S2 46 58
ESTRADIOL 60 60 R 47 102
FLUOXETINE HCL 56 38 48 38
IRBESARTAN 56 56 48 280
CRESTOR 55 55 50 30
SPIRONOLACTONE 55 55 50 55
KLOR-CON 8 55 55 50 317
OLANZAPINE 52 52 53 103
BISOPROLOL-HYDROCHLOROTHIAZIDE 52 52 53 174
FLUTICASONE PROPIONATE 51 48 55 26
SINGULAIR 50 43 56 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.